Foothold Labs is a startup focusing on developing next-generation rapid diagnostic platforms for point-of-care healthcare applications. Their flagship product, the NanoRev System, utilizes artificial intelligence-enabled electrochemical biosensors to rapidly detect infectious disease-related biomarkers in saliva within five minutes, and at a cost of under $35 per test. The company has established crucial partnerships with the Naval Research Laboratory, MIT Chemistry, and the University of Kansas Bioengineering program.
One of the company's significant achievements is securing more than $1.5MM in SBIR grant funding from the US Air Force and the US Special Operations Command within the past twelve months (as of May 2022). This is a clear indicator of the company's potential and the recognition it has received in the industry.
Founded in 2017, Foothold Labs has positioned itself as a promising player in the field, targeting the impactful areas of Next-Generation electrochemical sensors. The company's slogan, "Bringing lab-quality capabilities to the field for the DoD and first responders," highlights its focus on addressing critical needs for defense and emergency response sectors.
There is no investment information
No recent news or press coverage available for Foothold Labs.